📰 Chat Date News
Page 2 - Chat Date News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chat Date. Real-time updates on events, politics, business and more.
June 3, 2023
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced it will participate in the upcoming investor conferences:Event: Jefferies Healt...
June 2, 2023
EMERYVILLE, Calif., June 01, 2023 -- Gritstone bio, Inc. , a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be... | June 1, 2023
June 2, 2023
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the... | June 2, 2023
June 2, 2023
Legend Biotech Corporation , a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced it will participate in... | June 10, 2023
May 8, 2023
EMERYVILLE, Calif., May 08, 2023 -- 4D Molecular Therapeutics, Inc. , a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large... | May 8, 2023
May 8, 2023
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: BofA Securities 2023 Health...
April 11, 2023
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer...
March 8, 2023
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Barclays Global Healthcare...
February 28, 2023
28.02.2023 - Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate in a fireside chat and host in-person 1x1 ...
February 7, 2023
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer...